GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Total Debt per Share

Piramal Pharma (NSE:PPLPHARMA) Total Debt per Share : ₹35.74 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Total Debt per Share?

₹35.74 (As of Mar. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Piramal Pharma's Total Debt Per Share for the quarter that ended in Mar. 2024 was ₹35.74.

Piramal Pharma Total Debt per Share Historical Data

The historical data trend for Piramal Pharma's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Total Debt per Share Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Total Debt per Share
1.43 33.92 46.32 35.74

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.32 - 34.41 - 35.74

Piramal Pharma Total Debt per Share Calculation

Piramal Pharma's Total Debt Per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(26,017+21,084)/1,318
=35.74

Piramal Pharma's Total Debt Per Share for the quarter that ended in Mar. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(26,017+21,084)/1,318
=35.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Piramal Pharma Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Total Debt per Share
Comparable Companies
BOM:533573 BOM:524816 BOM:543064 BOM:506820 BOM:540596 BOM:500126 BOM:540222 BOM:532482 BOM:524742 BOM:543322 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
543635:India
Address
Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070
Website
https://www.piramal.com
Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines